Blog Posts

“DOSE OF REALITY” Big Pharma’s True Track Record Is A Hard Pill To Swallow: Part III

Feb 19, 2019

In advance of the U.S. Senate Committee on Finance hearing on February 26, Read More

DOSE OF REALITY: Big Pharma’s True Track Record Is A Hard Pill To Swallow – Part II

Feb 18, 2019

In advance of the U.S. Senate Committee on Finance hearing on February 26, Read More

DOSE OF REALITY: Big Pharma’s True Track Record Is A Hard Pill To Swallow – Part I

Feb 15, 2019

As bipartisan momentum to hold Big Pharma accountable and take action on Read More

They Said It! House Lawmakers Agree Bipartisan Action Needed To Bring Down Drug Prices

Feb 13, 2019

On Tuesday, the U.S. House Committee on Ways & Means held the third Read More

What they’re Saying: Reactions to Congress’ Drug Pricing Hearings

Feb 2, 2019

On Tuesday, the U.S. House Oversight and Reform and Senate Finance Committees Read More

THEY SAID IT! Drug Companies Have Been Warned

Jan 31, 2019

Drug Companies Have Been Warned: House & Senate Chairmen & Ranking Read More

Second Opinion: R&D Is Not To Blame For Skyrocketing Drug Costs

Jan 17, 2019

The jig is up – a new report showsthat “the skyrocketing cost of many Read More

Second Opinion: No, Big Pharma Is Not Changing

Jan 11, 2019

Right on cue, dozens of pharmaceutical companies rang in the new year by Read More

Second Opinion: Big Pharma’s Back At It

Dec 3, 2018

If at first you don’t succeed try, try again.  That’s the old adage Big Read More

It’s Time To Go To Work To Lower Prescription Drug Prices

Nov 12, 2018

Now that the midterms are over, it is now time for candidates to do what they Read More

On Message: Big Pharma Executives Double Down On Monopolistic Business Strategy

Nov 6, 2018

Executives of three major drug manufacturers – Pfizer, Merck and AbbVie – Read More

Voters want solutions to out-of-control drug prices

Nov 2, 2018

The American economy may be booming and paychecks may be growing Read More